Evidence map›Paper›PMID 26358770›Full record

ArticleHuman molecular genetics2015

Mitochondrial ATP synthase activity is impaired by suppressed O-GlcNAcylation in Alzheimer's disease.

Moon-Yong Cha, Hyun Jin Cho, Chaeyoung Kim, Yang Ouk Jung, Min Jueng Kang, Melissa E Murray, Hyun Seok Hong, Young-Joo Choi, Heesun Choi, Dong Kyu Kim and 9 more

Open access · bronzeAbstract read
In one paragraph

Article in Human molecular genetics, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 55 papers.

0numbers the graph read from it
0cells of the map it votes in
55citing papers in PubMed
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

55 citing papers in PubMed, 86 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 6 institutions in 2 countries.

Moon-Yong ChaDepartment of Biochemistry and Biomedical Sciences, Seoul National University, College of Medicine, Seoul, Korea.
Hyun Jin ChoDepartment of Biochemistry and Biomedical Sciences, Seoul National University, College of Medicine, Seoul, Korea.
Chaeyoung KimDepartment of Neuroscience, Mayo Clinic College of Medicine, Jacksonville, FL 32224, USA.
Yang Ouk JungDepartment of Life Sciences, Korea University, Seoul, Korea.
Min Jueng KangDepartment of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, School of Medicine and School of Pharmacy, Seoul National University, Seoul, Korea.
Melissa E MurrayDepartment of Neuroscience, Mayo Clinic College of Medicine, Jacksonville, FL 32224, USA.
Hyun Seok HongMedifron-DBT, Inc., Gyeonggi-do, Korea.
Young-Joo ChoiDepartment of Biochemistry and Biomedical Sciences, Seoul National University, College of Medicine, Seoul, Korea.
Heesun ChoiDepartment of Biochemistry and Biomedical Sciences, Seoul National University, College of Medicine, Seoul, Korea.
Dong Kyu KimDepartment of Biochemistry and Biomedical Sciences, Seoul National University, College of Medicine, Seoul, Korea.
Hyunjung ChoiDepartment of Biochemistry and Biomedical Sciences, Seoul National University, College of Medicine, Seoul, Korea.
Jisoo KimDepartment of Biochemistry and Biomedical Sciences, Seoul National University, College of Medicine, Seoul, Korea.
Dennis W DicksonDepartment of Neuroscience, Mayo Clinic College of Medicine, Jacksonville, FL 32224, USA.
Hyun Kyu SongDepartment of Life Sciences, Korea University, Seoul, Korea.
Jin Won ChoDepartment of Integrated OMICS for Biomedical Science, Graduate School, Yonsei University, Seodaemun-gu, Seoul, Korea and.
Eugene C YiDepartment of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, School of Medicine and School of Pharmacy, Seoul National University, Seoul, Korea.
Jungsu KimDepartment of Neuroscience, Mayo Clinic College of Medicine, Jacksonville, FL 32224, USA.
Seok Min JinDepartment of Biochemistry and Biomedical Sciences, Seoul National University, College of Medicine, Seoul, Korea, inhee@snu.ac.kr neurocom@snu.ac.kr.
Inhee Mook-JungDepartment of Biochemistry and Biomedical Sciences, Seoul National University, College of Medicine, Seoul, Korea, inhee@snu.ac.kr neurocom@snu.ac.kr.
Seoul National University · KRKorea University · KRMayo Clinic in Florida · USWinnMed · USJacksonville College · USYonsei University · KR

Funding

Vascular Structure and Function in Cognitive AgingP01AG003949 · NIA · YESHIVA UNIVERSITY · PI Richard B. LIPTON · 1985 to 2026
$73.9M
THE PGRN/TDP-43 AXIS IN ALZHEIMER?S DISEASE AND NEURODEGENERATIONP50AG016574 · NIA · MAYO CLINIC ROCHESTER · PI BU, GUOJUN · 1999 to 2018
$36.9M
NIA NIH HHS AG016574NIA NIH HHS P01 AG003949NIA NIH HHS P01-AG03949NIA NIH HHS P50 AG016574
6 · The paper itself

Abstract

Glycosylation with O-linked β-N-acetylglucosamine (O-GlcNAc) is one of the protein glycosylations affecting various intracellular events. However, the role of O-GlcNAcylation in neurodegenerative diseases such as Alzheimer's disease (AD) is poorly understood. Mitochondrial adenosine 5'-triphosphate (ATP) synthase is a multiprotein complex that synthesizes ATP from ADP and Pi. Here, we found that ATP synthase subunit α (ATP5A) was O-GlcNAcylated at Thr432 and ATP5A O-GlcNAcylation was decreased in the brains of AD patients and transgenic mouse model, as well as Aβ-treated cells. Indeed, Aβ bound to ATP synthase directly and reduced the O-GlcNAcylation of ATP5A by inhibition of direct interaction between ATP5A and mitochondrial O-GlcNAc transferase, resulting in decreased ATP production and ATPase activity. Furthermore, treatment of O-GlcNAcase inhibitor rescued the Aβ-induced impairment in ATP production and ATPase activity. These results indicate that Aβ-mediated reduction of ATP synthase activity in AD pathology results from direct binding between Aβ and ATP synthase and inhibition of O-GlcNAcylation of Thr432 residue on ATP5A.

Indexed as

AcetylglucosamineAdenosine TriphosphateAlzheimer DiseaseAnimalsbeta-N-AcetylhexosaminidasesCHO CellsCricetulusDisease Models, AnimalGlycosylationHeLa CellsHumansMiceMice, TransgenicMitochondriaMitochondrial Proton-Translocating ATPasesN-AcetylglucosaminyltransferasesAcetylglucosamineAdenosine Triphosphatebeta-N-AcetylhexosaminidasesF(6) ATPasehexosaminidase CMitochondrial Proton-Translocating ATPasesN-AcetylglucosaminyltransferasesO-GlcNAc transferaseOxidative Phosphorylation Coupling FactorsUDP-N-acetylglucosamine-peptide beta-N-acetylglucosaminyltransferase

Identifiers

PMID26358770
PMCPMC5007609
OpenAlexW1886846543

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.